Literature DB >> 28682305

IFN-γ promotes transendothelial migration of CD4+ T cells across the blood-brain barrier.

Sandip Ashok Sonar1, Shagufta Shaikh1, Nupura Joshi1, Ashwini N Atre1, Girdhari Lal1.   

Abstract

Transendothelial migration (TEM) of Th1 and Th17 cells across the blood-brain barrier (BBB) has a critical role in the development of experimental autoimmune encephalomyelitis (EAE). How cytokines produced by inflammatory Th1 and Th17 cells damage the endothelial BBB and promote transendothelial migration of immune cells into the central nervous system (CNS) during autoimmunity is not understood. We therefore investigated the effect of various cytokines on brain endothelial cells. Among the various cytokines tested, such as Th1 (IFN-γ, IL-1α, IL-1β, TNF-α, IL-12), Th2 (IL-3, IL-4, IL-6 and IL-13), Th17 (IL-17A, IL-17F, IL-21, IL-22, IL-23, GM-CSF) and Treg-specific cytokines (IL-10 and TGF-β), IFN-γ predominantly showed increased expression of ICAM-1, VCAM-1, MAdCAM-1, H2-Kb and I-Ab molecules on brain endothelial cells. Furthermore, IFN-γ induced transendothelial migration of CD4+ T cells from the apical (luminal side) to the basal side (abluminal side) of the endothelial monolayer to chemokine CCL21 in a STAT-1-dependent manner. IFN-γ also favored the transcellular route of TEM of CD4+ T cells. Multicolor immunofluorescence and confocal microscopic analysis showed that IFN-γ induced relocalization of ICAM-1, PECAM-1, ZO-1 and VE-cadherin in the endothelial cells, which affected the migration of CD4+ T cells. These findings reveal that the IFN-γ produced during inflammation could contribute towards disrupting the BBB and promoting TEM of CD4+ T cells. Our findings also indicate that strategies that interfere with the activation of CNS endothelial cells may help in controlling neuroinflammation and autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28682305     DOI: 10.1038/icb.2017.56

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  49 in total

1.  A role for MHC class I molecules in synaptic plasticity and regeneration of neurons after axotomy.

Authors:  Alexandre L R Oliveira; Sebastian Thams; Olle Lidman; Fredrik Piehl; Tomas Hökfelt; Klas Kärre; Hans Lindå; Staffan Cullheim
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-10       Impact factor: 11.205

2.  Persistent endothelial abnormalities and blood-brain barrier leak in primary and secondary progressive multiple sclerosis.

Authors:  S Leech; J Kirk; J Plumb; S McQuaid
Journal:  Neuropathol Appl Neurobiol       Date:  2007-02       Impact factor: 8.090

3.  A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes.

Authors:  Shinsuke Nakagawa; Mária A Deli; Hiroko Kawaguchi; Takeshi Shimizudani; Takanori Shimono; Agnes Kittel; Kunihiko Tanaka; Masami Niwa
Journal:  Neurochem Int       Date:  2008-12-07       Impact factor: 3.921

4.  Cutting edge: loss of α4 integrin expression differentially affects the homing of Th1 and Th17 cells.

Authors:  Simon Glatigny; Rebekka Duhen; Mohamed Oukka; Estelle Bettelli
Journal:  J Immunol       Date:  2011-11-14       Impact factor: 5.422

5.  The interdependent, overlapping, and differential roles of type I and II IFNs in the pathogenesis of experimental autoimmune encephalomyelitis.

Authors:  Rodrigo Naves; Simer P Singh; Kevin S Cashman; Amber L Rowse; Robert C Axtell; Lawrence Steinman; John D Mountz; Chad Steele; Patrizia De Sarno; Chander Raman
Journal:  J Immunol       Date:  2013-08-19       Impact factor: 5.422

6.  IFN-γ-dependent activation of the brain's choroid plexus for CNS immune surveillance and repair.

Authors:  Gilad Kunis; Kuti Baruch; Neta Rosenzweig; Alexander Kertser; Omer Miller; Tamara Berkutzki; Michal Schwartz
Journal:  Brain       Date:  2013-10-01       Impact factor: 13.501

7.  Expression of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 in the spinal cord of rats during acute experimental allergic encephalomyelitis.

Authors:  M Matsuda; N Tsukada; C S Koh; T Iwahashi; K Shimada; N Yanagisawa
Journal:  Autoimmunity       Date:  1994       Impact factor: 2.815

8.  Th17 lymphocytes traffic to the central nervous system independently of α4 integrin expression during EAE.

Authors:  Veit Rothhammer; Sylvia Heink; Franziska Petermann; Rajneesh Srivastava; Malte C Claussen; Bernhard Hemmer; Thomas Korn
Journal:  J Exp Med       Date:  2011-10-24       Impact factor: 14.307

9.  Cutting edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis.

Authors:  Richard A O'Connor; Catriona T Prendergast; Catherine A Sabatos; Clement W Z Lau; Melanie D Leech; David C Wraith; Stephen M Anderton
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

10.  In vitro model of the blood-brain barrier established by co-culture of primary cerebral microvascular endothelial and astrocyte cells.

Authors:  Yan Wang; Ning Wang; Biao Cai; Guang-Yun Wang; Jing Li; Xing-Xing Piao
Journal:  Neural Regen Res       Date:  2015-12       Impact factor: 5.135

View more
  23 in total

1.  Immunopathology and Trypanosoma congolense parasite sequestration cause acute cerebral trypanosomiasis.

Authors:  Sara Silva Pereira; Mariana De Niz; Karine Serre; Marie Ouarné; Joana E Coelho; Cláudio A Franco; Luisa M Figueiredo
Journal:  Elife       Date:  2022-07-05       Impact factor: 8.713

Review 2.  Profiles of Proinflammatory Cytokines and T Cells in Patients With Tourette Syndrome: A Meta-Analysis.

Authors:  Ying Li; Xiaolin Wang; Hanxue Yang; Yanlin Li; Jingang Gui; Yonghua Cui
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

3.  IL-11 antagonist suppresses Th17 cell-mediated neuroinflammation and demyelination in a mouse model of relapsing-remitting multiple sclerosis.

Authors:  Xin Zhang; Nazanin Kiapour; Sahil Kapoor; Joseph R Merrill; Yongjuan Xia; Woomi Ban; Stephanie M Cohen; Bentley R Midkiff; Valerie Jewells; Yen-Yu I Shih; Silva Markovic-Plese
Journal:  Clin Immunol       Date:  2018-08-24       Impact factor: 3.969

4.  MAdCAM-1 mediates retinal neuron degeneration in experimental colitis through recruiting gut-homing CD4+ T cells.

Authors:  Kun Peng; Jie Xiao; Jinxia Wang; Yaxin Song; Lianying Wu; Wenbo Xiu; Qinyuan Chen; Yanxi Chen; Ping Shuai; Chong He; Fang Lu
Journal:  Mucosal Immunol       Date:  2020-03-16       Impact factor: 7.313

5.  Prognosis Markers for Monitoring HTLV-1 Neurologic Disease.

Authors:  Gabriela Prates; Tatiane Assone; Marcelo Corral; Maíra P M Baldassin; Tatiane Mitiko; Flávia C Silva Sales; Michel E Haziot; Jerusa Smid; Luiz A M Fonseca; Fernanda de Toledo Gonçalves; Augusto C Penalva de Oliveira; Jorge Casseb
Journal:  Neurol Clin Pract       Date:  2021-04

Review 6.  Differentiation and Transmigration of CD4 T Cells in Neuroinflammation and Autoimmunity.

Authors:  Sandip Ashok Sonar; Girdhari Lal
Journal:  Front Immunol       Date:  2017-11-29       Impact factor: 7.561

Review 7.  Brain Metastasis Organotropism.

Authors:  Arseniy E Yuzhalin; Dihua Yu
Journal:  Cold Spring Harb Perspect Med       Date:  2020-05-01       Impact factor: 6.915

8.  West Nile Virus-Induced Neurologic Sequelae-Relationship to Neurodegenerative Cascades and Dementias.

Authors:  Amy Y Vittor; Maureen Long; Paramita Chakrabarty; Lauren Aycock; Vidya Kollu; Steven T DeKosky
Journal:  Curr Trop Med Rep       Date:  2020-02-18

9.  Rac1/Wave2/Arp3 Pathway Mediates Rat Blood-Brain Barrier Dysfunction under Simulated Microgravity Based on Proteomics Strategy.

Authors:  Ranran Yan; Huayan Liu; Fang Lv; Yulin Deng; Yujuan Li
Journal:  Int J Mol Sci       Date:  2021-05-13       Impact factor: 5.923

10.  m6A demethylase ALKBH5 controls CD4+ T cell pathogenicity and promotes autoimmunity.

Authors:  Jing Zhou; Xingli Zhang; Jiajia Hu; Rihao Qu; Zhibin Yu; Hao Xu; Huifang Chen; Lichong Yan; Chenbo Ding; Qiang Zou; Youqiong Ye; Zhengting Wang; Richard A Flavell; Hua-Bing Li
Journal:  Sci Adv       Date:  2021-06-16       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.